Abstract Hyponatremia is one of the adverse effects in patients treated with oxcarbazepine. This can be seen masked by multiple symptoms which are simply attributable to other diseases, but we must always keep it in mind in a patient with a history of taking that medication. Many of patients are asymptom...
Introdução: a tríade clássica composta por progressiva disfunção neurológica, associada à surdez, e alterações visuais, foi descrita inicialmente em 1979 por Susac et. al. Rara, entretanto, com grande potencial de destruição, a Síndrome de Susac (SS)
sempre deve ser aventada por otorrinolari...
ABSTRACT Autoantibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been reported in patients with inflammatory central nervous system disorders including isolated optic neuritis (ON). We compared our MOG-IgG ON patients with multiple sclerosis (MS) patients presenting with ON. Methods and...
RESUMO Introdução: a esclerose múltipla (EM) é uma Doença desmielinizante de etiologia autoimune, e está entre as principais causas de incapacidade neurológica não traumática nos adultos jovens. Objetivo: identificar os principais diagnósticos, resultados e intervenções de enfermagem e val...
ABSTRACT The polyspecific antibody synthesis in multiple sclerosis (MS) gained diagnostic relevance with the frequent combination of measles-, rubella- and varicella zoster antibodies (MRZ-antibody reaction) but their pathophysiological role remains unknown. This review connects the data for intrathecal ...
Anticuerpos Antibacterianos,
Anticuerpos Antivirales/sangre,
Especificidad de Anticuerpos/inmunología,
Antígenos Virales/inmunología,
Líquido Cefalorraquídeo/química,
Síndrome de Guillain-Barré/inmunología,
Herpes Zóster/inmunología,
Inmunoglobulina G/sangre,
Sarampión/inmunología,
Esclerosis Múltiple/líquido cefalorraquídeo,
Esclerosis Múltiple/inmunología,
Paperas/inmunología,
Rubéola (Sarampión Alemán)/inmunología
Abstract Background and objectives: Current guidelines for neuraxial analgesia in patients with multiple sclerosis are ambiguous and offer the clinician only a limited basis for decision making. This systematic review examines the number of cases in which multiple sclerosis has been exacerbated after ce...
ABSTRACT Late onset multiple sclerosis (LOMS) is when the first symptom starts after 50 years of age, representing 4.5% of multiple sclerosis (MS) patients. This study describes the clinical characteristics of patients with LOMS followed at a specialized MS center in São Paulo. Data was obtained from me...
ABSTRACT Objective The treatment of multiple sclerosis (MS) has quickly evolved from a time when controlling clinical relapses would suffice, to the present day, when complete disease control is expected. Measurement of brain volume is still at an early stage to be indicative of therapeutic decisions i...
ABSTRACT CONTEXT AND OBJECTIVE: Multiple sclerosis (MS) is a chronic, immune-mediated and degenerative central nervous system (CNS) disease with well-established diagnostic criteria. Treatment can modify the course of the disease. The objective of this study was to describe the initial symptoms of mult...
